NeuroCare aims to create better retinal, cortical and cochlear implantable devices through the use of improved interfacing between the electronic implants and living cells. The NeuroCare concept involves low-cost, carbon-based mat...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
INCA-NANEP
INterfacing CArbon based NAnomaterials to neurons toward ne...
170K€
Cerrado
ASTROTECH
Disruptive materials technologies approaches to unravel...
4M€
Cerrado
FUNMANIA
Functional nano Materials for Neuronal Interfacing Applicati...
1M€
Cerrado
NANeurO
Injectable nanoelectrodes for wireless and minimally invasiv...
1M€
Cerrado
MERIDIAN
Micro and Nano Engineered Bi Directional Carbon Interfaces f...
5M€
Cerrado
CROSSBRAIN
Distributed and federated cross-modality actuation through a...
4M€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
NeuroCare aims to create better retinal, cortical and cochlear implantable devices through the use of improved interfacing between the electronic implants and living cells. The NeuroCare concept involves low-cost, carbon-based materials, well-adapted for medical implants, because they (i) offer wide range of electronic properties (metal, semiconductor and insulator), (ii) are bio-inert and (iii) are physically robust. Coupling between electronic devices and neurons was recently studied using soft, nanocrystalline diamond-based micro-electrode arrays, evaluated in laboratory animals for retinal stimulation. These diamond implants considerably reduced gliosis, enabled stimulation currents to be raised by more than one order of magnitude before causing visible chemical alteration, and enabled long lasting operation with reduced biofouling. Our previous experience with nanocrystalline diamond will be directly built upon through the introduction of atomic layers of graphene to diamond surfaces.
NeuroCare will specifically focus on:
• Carbon-biointerface development offering reduced biofouling over the state-of-the-art, as set by the DREAMS project and improved biocompatibility
• Interfacing of rigid MEAs and FETs with cells and organs to improve bidirectional communication with neurons for in vitro research and pharmacological applications
• Nanoscale surface engineering and flexible macroscale implant materials for optimal contact to biological tissue
• Making and testing implantable MEAs and FETs for complex multichannel neuronal communication - targeting the specificity in vivo of the implantable devices for 3 high-impact clinical applications
Neurocare partners will test interfaceable and implantable devices via in vitro and in vivo testing.
NeuroCare federates 12 partners: CEA (LIST and CLINATEC), Ecole Supérieure d'Ingénieurs en Electronique, Forschungszentrum Jülich, Ayanda Biosystems SA, University College London (London Centre for Nanotechnology), Johannes